Trial Profile
A Randomized, Double-blind, 2-Period, 2-Sequence Crossover Phase I Study With a 1 Month run-in Period to Examine the Effect of Cladribine Tablets on the PK of a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel (Microgynon) in Pre-Menopausal Women With RMS
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Mar 2024
Price :
$35
*
At a glance
- Drugs Cladribine (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- Sponsors Merck KGaA
- 21 Oct 2022 Status changed from active, no longer recruiting to completed.
- 08 Feb 2022 Status changed from recruiting to active, no longer recruiting.
- 13 Jan 2022 Planned End Date changed from 31 Jan 2022 to 3 Jun 2022.